SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso(University of California, San Francisco), Bryan Greenhouse(San Francisco General Hospital), Timothy J. Henrich(University of California, San Francisco), Jeffrey N. Martin(University of California, San Francisco), Matthew A. Spinelli(University of California, San Francisco), Joanna Donatelli(University of California, San Francisco), Monica Gandhi(University of California, San Francisco), Jeffrey I. Cohen(National Institute of Allergy and Infectious Diseases), Mary-Ann Palafox(Abbott Fund), Xin Zhou(Harvard University), Rebecca Hoh(University of California, San Francisco), Mary A. Rodgers(Abbott Fund), Terri Wrin, Saki Takahashi(Fukuoka Dental College), Susanna K. Elledge(University of California, San Francisco), Charles Y. Chiu(University of California, San Francisco), Peter D. Burbelo(National Institutes of Health), John C. Prostko(Abbott Fund), Christos J. Petropoulos, Viva Tai(University of California, San Francisco), Isabel Rodríguez-Barraquer(University of California, San Francisco), Keirstinne Turcios(University of California, San Francisco), Nikita S. Iyer(University of California, San Francisco), Philip J. Norris(University of California, San Francisco), Emily A. Fehrman(University of California, San Francisco), Mars Stone(Pacific Research Institute), John E. Pak(Chan Zuckerberg Initiative (United States)), James A. Wells(University of California, San Francisco), Rachel L. Rutishauser(San Francisco General Hospital), Cassandra Thanh(University of California, San Francisco), Jill Hakim(University of California, San Francisco), Michael P. Busch(University of California, San Francisco), Steven G. Deeks(University of California, San Francisco), Leonel Torres(University of California, San Francisco), J. Daniel Kelly(University of California, San Francisco), Wesley Wu(Chan Zuckerberg Initiative (United States)), Yanel Hernandez(University of California, San Francisco), Ana Vallari(Abbott Fund), Theodore W. Kurtz(University of California, San Francisco), John Hackett(Abbott Fund), Clara DiGermanio(Pacific Research Institute), Lan Trinh, Christopher C. Nixon(University of California, San Francisco), Albert C. Shu(University of California, San Francisco), Sadie E. Munter(University of California, San Francisco), Owen Janson(University of California, San Francisco)
Cited by 150
Related Papers
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
|Circulation|2005|4k
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
|Hypertension|2004|2.1k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
|Proceedings of the National Academy of Sciences|2003|1.2k